跳至主要内容
临床试验/ACTRN12616001303437
ACTRN12616001303437招募中未知

Multicentre Tasmanian Study of a Multidisciplinary Intervention to Reduce Readmission and Death of Patients admitted with Heart Failure

niversity of Tasmania0 个研究点目标入组 412 人开始时间: 2016年9月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
412

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Admission to hospital with heart failure

排除标准

  • - Unable to provide written informed consent to participate in this study
  • - Participating in another clinical research trial where randomized treatment would be unacceptable
  • - Moderate or worse primary mitral or aortic valve disease
  • - Any HF admission within the last 6 months
  • - Concomitant unstable angina, acute myocardial infarction
  • - Device malfunction, endocarditis
  • - Patients with LVAD
  • - Potentially reversible LV dysfunction – post-partum, alcoholic cardiomyopathy, hyperthyroidism
  • - Concomitant terminal non-cardiac illnesses that could influence 12 month prognosis (e.g. advanced malignancy),
  • - Inability to acquire interpretable images (identified from baseline echo)

研究者

发起方
niversity of Tasmania

相似试验